RP Management, LLC
- SEC CIK
- 0001507673
- Latest filing
- Aug 6, 2025
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 12, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 3
- −1 vs. Q1 2021
- Portfolio value
- $184.1M
- −$60.5M (−24.7%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 1,111,111 | $107.9M | 58.6% | −1,000,000−47.4% | Reduced | History |
| EPZMEpizyme, Inc. | COM | 9,166,667 | $76.2M | 41.4% | 00.0% | Unchanged | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,700 | $42.0K | <0.1% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Epizyme Inc29428V904 | CALL | – | $21.0M |
Sold out since Q1 2021 (1)
Positions held at the end of Q1 2021 that are gone from this filing.